Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study

Authors

Zhi Wang (ORCID: https://orcid.org/0000-0002-5002-5025)
Haidi Wu
Yan‐Jun Du (ORCID: https://orcid.org/0000-0001-9533-8976)
Min Zhou (ORCID: https://orcid.org/0000-0003-4692-7234)
Wenyan Kang (ORCID: https://orcid.org/0000-0001-7527-7512)
Jieming Qu (ORCID: https://orcid.org/0000-0003-0464-544X)
Xiang Li (ORCID: https://orcid.org/0000-0001-6023-8561)
H. Wei (ORCID: https://orcid.org/0000-0003-1973-4912)
Hongwei Xu (ORCID: https://orcid.org/0009-0000-9490-7196)
Wenbo Shi
Zhidong Gu (ORCID: https://orcid.org/0000-0003-4558-9106)
Jianhua You
Jiaxin Tian
Jianru Wen

Institutions

Shanghai Jiao Tong University (CN)
Ruijin Hospital (CN)
Shanghai Eye Disease Prevention & Treatment Center (CN)
Hainan 301 Hospital (CN)

Publication Details

Journal: Virology Journal
Published: 2024-10-24
DOI: https://doi.org/10.1186/s12985-024-02509-5
Primary Topic: SARS-CoV-2 and COVID-19 Research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

AstraZeneca

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study

Zhi Wang, Haidi Wu, Yan‐Jun Du, Min Zhou et al.

Oct 24, 2024

Virology Journal

SARS-CoV-2 and COVID-19 Research

article

Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study

Zhi Wang, Haidi Wu, Yan‐Jun Du, Min Zhou, Wenyan Kang, Jieming Qu, Xiang Li, H. Wei, Hongwei Xu, Wenbo Shi, Zhidong Gu, Jianhua You, Jiaxin Tian, Jianru Wen

October 24, 2024article en

Abstract

No abstract available for this paper.

Virology JournalVol. 21(1)

Shanghai Jiao Tong University (CN), Ruijin Hospital (CN), Shanghai Eye Disease Prevention & Treatment Center (CN), Hainan 301 Hospital (CN)

AstraZeneca

Zero hunger

Openalex Percentile: Top 77%

SARS-CoV-2 and COVID-19 Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.